OVER DEZE AFLEVERING
June 27th 2024 – Join us this week as we speak with Kevin Neil and Jean-François Millau from Tatum Bioscience in Sherbrooke, Quebec. Kevin and Jean-François are a part of a team that are ‘programming’ bacteria to turn them into cancer-fighting drugs and the work they are doing is cutting edge.
TATUM Bioscience: tatumbio.com
Get Your Tickets to The NGBI Summit: nextgreatbigideas.com
Lab Occupier: laboccupier.com
Engels
Verenigde Staten
TRANSCRIPTIE 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
OUDE AFLEVERINGEN ZOEKEN
Zoek naar eerdere afleveringen van NGBiLab.
ANDERE AFLEVERINGEN IN DEZE PODCAST
In this episode, we delve into the groundbreaking work of Dr. Jeffrey Coull and his team at Grey Matter Neurosciences. Discover how their pioneering ultrasound technology aims to enhance cognitive function in patients with Alzheimer's and other cognitive impairments. Join us as we explore the poten…
Join host Jim Wilson as he sits down with Nabanita Nawar, co-founder of HDAX Therapeutics, to explore the groundbreaking work in targeting disease driver proteins for novel medicine development. Discover the journey from academic research to entrepreneurial success, and learn about the innovative t…
Disclaimer: De podcast en de illustraties die op deze pagina zijn ingesloten, zijn afkomstig van Jim Wilson, eigendom van de eigenaar en niet gelieerd aan of goedgekeurd door Listen Notes, Inc.
BEWERKEN
Bedankt voor uw hulp bij het up-to-date te houden van de podcast-database .
